2020
|
Invention
|
Choline esters.
Compounds, formulations, and methods are provided containing the choline ester o... |
2016
|
Invention
|
Dithiol compounds, derivatives, and uses therefor. Dithiol compounds and derivatives thereof are ... |
2015
|
Invention
|
Low dose lipoic acid pharmaceutical compositions and methods. Compositions containing low doses o... |
2014
|
Invention
|
Choline esters. Compounds, formulations, and methods are provided containing the choline ester of... |
|
Invention
|
Methods of treating ocular diseases using derivatives of lipoic acid. Dithiol compounds and deriv... |
|
Invention
|
Presbyopia treatment by lens alteration. This invention effects a change in the accommodation of ... |
|
Invention
|
Dithiol compounds and treatment of presbyopia using said compounds. Dithiol compounds and derivat... |
2011
|
Invention
|
Presbyopia treatment by lens alteration of disulfide bonds and reduction. This invention effects ... |
2010
|
Invention
|
Methods of treating ocular diseases using derivatives of lipoic acid. Methods of treating ocular ... |
2009
|
Invention
|
Mercaptan and seleno-mercaptan compounds and methods of using them. Novel mercaptan compounds, pa... |
|
Invention
|
Dithiol compounds, derivatives, and treatment of presbyopia. Dithiol compounds and derivatives th... |
2008
|
Invention
|
Low dose lipoic and pharmaceutical compositions and methods. Compositions containing low doses of... |
|
Invention
|
Caged mercaptan and seleno-mercaptan compounds and methods of using them. Novel mercaptan compoun... |
2007
|
Invention
|
Presbyopia treatment by lens alteration. Embodiments of the present invention relate to methods a... |
2005
|
Invention
|
Method for delivery of pharmaceuticals for treating or preventing presbyopia. Embodiments of the ... |
2004
|
Invention
|
Presbyopia treatment by lens alteration.
Embodiments of the present invention relate to methods ... |
2002
|
Invention
|
Presbyopia treatment by reducing and preventing lenticular disulfide crosslinks. This invention e... |